Juvenile Arthritis News

A newly formed organization, the COVID-19 Global Rheumatology Alliance, has launched an international registry to collect data on patients with rheumatic diseases who may or may not have contracted the infection that is causing the global pandemic. The aim is to aid clinicians and researchers in real time as the situation evolves.

Many patients with juvenile idiopathic arthritis see little benefit from treatment with their first or second biologic, according to data published in The Lancet Rheumatology.

A review of 75 adalimumab clinical trials in adult and pediatric patients demonstrated low rates of inflammatory bowel disease adverse events, according to data published in Arthritis Care & Research.

The situation with COVID-19, or the currently circulating coronavirus, is developing so rapidly that new information may likely be available by the time you reach the end of this paragraph. But along with factual information, misinformation also abounds on social media, on cable news channels and in print publications. Healio Rheumatology will attempt to set the record straight for health care providers looking to sort out fact from fiction.

Anakinra was effective in pediatric patients with non–malignancyassociated secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome, particularly when administered early and in those with underlying rheumatic disease, according to data published in Arthritis & Rheumatology.

The United Rheumatology Spring National Meeting will offer attendees lectures on cutting edge topics such as genomics and transcriptomics in addition to a range of continuing medical education activities. But the real appeal of United Rheumatology, and of the meeting, will be the guidance that can be provided to independent rheumatologists regarding practice management strategies and interacting with payers.

Tocilizumab failed to meet its primary endpoint of treatment response in patients with uveitis associated with juvenile idiopathic arthritis, according to phase 2 trial findings published in The Lancet Rheumatology.

Approximately 35% of relevant industry payments to U.S.-based authors of American College of Rheumatology clinical practice guidelines remain undisclosed, according to findings published in Arthritis & Rheumatology.

MAUI, Hawaii — Lung complications in systemic juvenile idiopathic arthritis are gaining more attention due to increased incidence, according to a presenter at the 2020 Rheumatology Winter Clinical Symposium.

With more than 300,000 children with arthritis and other rheumatic conditions across the United States, and fewer than 350 pediatric rheumatologists to treat them, Monica L. Friedman, DO, of Orlando Health Arnold Palmer Hospital for Children, is on the front lines of the growing rheumatology shortage.